Neurological Disorders Clinical Trials

8 recruiting

Neurological Disorders Trials at a Glance

9 actively recruiting trials for neurological disorders are listed on ClinicalTrialsFinder across 6 cities in 42 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Roma, Milan, and Basel. Lead sponsors running neurological disorders studies include Gametherapy, IRCCS Centro Neurolesi Bonino Pulejo, and Bielefeld University.

Browse neurological disorders trials by phase

Treatments under study

About Neurological Disorders Clinical Trials

Looking for clinical trials for Neurological Disorders? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Neurological Disorders trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Neurological Disorders clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting

Product Surveillance Registry

Cardiac Rhythm DisordersNeurological DisordersCardiovascular Disorders+1 more
Medtronic100,000 enrolled391 locationsNCT01524276
Recruiting

A Muscle-brain Interplay Study in Neurological Disorders

Health Adult SubjectsNeurological Disorders
Istituti Clinici Scientifici Maugeri SpA150 enrolled4 locationsNCT07477821
Recruiting
Not Applicable

Cognitive Recovery Via Sensor-based Robotic Upper Limb Rehabilitation in Neurological Disorders

StrokeMultiple SclerosisPARKINSON DISEASE (Disorder)+1 more
IRCCS Centro Neurolesi Bonino Pulejo189 enrolled1 locationNCT07384143
Recruiting

Validation of the VIRADIA App for Neurological and Cognitive Diagnostics in Virtual Reality

Cognitive ImpairmentNeurological Disorders
Gametherapy200 enrolled1 locationNCT07268079
Recruiting

Clinical Manifestations and Biomarkers in Amyotrophic Lateral Sclerosis Type 4 and Other Inherited Neurological Disorders of RNA Processing

Amyotrophic Lateral Sclerosis Type 4Inherited Neurological Disorders of RNA Processing
National Institute of Neurological Disorders and Stroke (NINDS)330 enrolled1 locationNCT04394871
Recruiting
Not Applicable

Neurologic Stem Cell Treatment Study

Cognitive ImpairmentDementiaTraumatic Brain Injury+23 more
MD Stem Cells500 enrolled3 locationsNCT02795052
Recruiting
Not Applicable

ACT for Mental Health in Neurological Disorders

Mental HealthNeurological DisordersExecutive Function (Cognition)
Bielefeld University44 enrolled1 locationNCT06897553
Recruiting

Exhaled Breath Analysis by Secondary Electrospray Ionization - Mass Spectrometry in Children and Adolescents

Type 1 DiabetesRespiratory DiseasesNeurological Disorders
University Children's Hospital Basel3,600 enrolled1 locationNCT04461821
Recruiting
Phase 4

Botulinum toxin injections into the salivary glands to reduce drooling in children

Excessive drooling in children with neurological disorders
Murdoch Children's Research Institute56 enrolled1 locationACTRN12605000379617